Ozempic vs Mounjaro for Weight Loss: Which Works Better in 2026?

Available online. Shipped directly to your door anywhere in the US.

Ozempic vs Mounjaro is the most-searched GLP-1 comparison in the US — and the answer is more nuanced than "one is stronger." Both are weekly injections that reduce appetite and slow gastric emptying, but they work through different mechanisms and produce measurably different average results in clinical trials. Here's the honest head-to-head.

Ozempic vs Mounjaro: quick comparison

Effectiveness: what the trials actually show

In the STEP-1 trial, semaglutide 2.4 mg produced 14.9% average body weight lossover 68 weeks. In SURMOUNT-1, tirzepatide 15 mg produced 20.9% average loss over 72 weeks — and the head-to-head SURMOUNT-5 trial confirmed tirzepatide's edge directly: roughly 20% vs 14% average reduction.

Translation: Mounjaro wins on average. But averages hide the real story — about 1 in 3 semaglutide users lose 20%+, and some people simply respond better to one molecule than the other. If you've plateaued on Ozempic after 6+ months at max dose, switching to tirzepatide is the standard next move.

Side effects: nearly identical profiles

Both drugs cause the same GI-dominant side effects, concentrated in the first 4-8 weeks and during dose increases:

• Nausea — most common (20-44% in trials), usually fades after titration
• Diarrhea / constipation — 15-30%, manageable with diet adjustments
• Vomiting — 5-25%, typically dose-related
• Discontinuation for side effects — ~4-7% for both drugs

Mounjaro's dual GIP/GLP-1 mechanism doesn't appear to worsen tolerability — if anything, some patients report slightly less nausea at equivalent weight-loss doses. See our Ozempic side effects guide and Mounjaro side effects guide for management strategies.

Cost: where they actually differ

Brand-name pricing is comparable (~$1,000+/month list), but the practical cost gap shows up in compounded versions and insurance coverage:

• Compounded semaglutide: $99-299/month through US telehealth — the cheapest legitimate entry point. See cheapest compounded semaglutide.
• Compounded tirzepatide: $249-449/month — roughly double, reflecting the newer molecule. See cheapest compounded tirzepatide.
• Insurance: coverage varies wildly by plan — check our GLP-1 cost guide for insurer-by-insurer breakdowns.

Which should you choose?

Start with Ozempic/semaglutide if:

• Budget matters — compounded semaglutide is half the price
• You want the longest safety track record (semaglutide since 2017)
• Your target is 10-15% body weight loss

Start with Mounjaro/tirzepatide if:

• You need maximum average results (20%+ target)
• You've plateaued on semaglutide — see our Ozempic to Mounjaro conversion guide
• You have insulin resistance or type 2 diabetes (dual mechanism advantage)

Frequently asked questions

Is Mounjaro better than Ozempic for weight loss?

On average yes — tirzepatide produced ~20-22% body weight loss vs ~15-17% for semaglutide in trials, confirmed head-to-head in SURMOUNT-5. Individual response varies, and semaglutide works extremely well for many patients.

Can I switch from Ozempic to Mounjaro?

Yes — it's the standard move after a semaglutide plateau. Providers start tirzepatide at 2.5 mg and titrate up. Read our conversion guide.

Which is cheaper?

Compounded semaglutide ($99-299/mo) is roughly half the cost of compounded tirzepatide ($249-449/mo). Brand-name list prices are similar (~$1,000+/mo).

Do they work the same way?

Mostly — both reduce appetite and slow digestion via GLP-1. Mounjaro adds GIP receptor activity, which appears to enhance fat loss and may improve tolerability for some patients.